Novartis



Ebit تغيير تاريخ
AbbVie USD 5.65B 407M 2025-03
Amgen USD 3.6B 434M 2025-03
AstraZeneca USD 4.8B 604M 2025-03
Bausch Health Companies USD 587M 41M 2025-03
Biogen USD 582.8M 61.3M 2025-03
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Canopy Growth CAD -23822000 22.12M 2024-12
Corcept Therapeutics USD 3.42M 21.85M 2025-03
Drreddys Laboratories INR 18.02B 1.22B 2024-12
Eli Lilly USD 3.7B 1.93B 2025-03
Gilead Sciences USD 2.89B 221M 2025-03
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Indivior 71M 30M 2025-03
J&J USD 7.39B 2.04B 2025-03
Merck USD 5.22B 339M 2024-12
Novartis USD 4.86B 286M 2024-12
Novartis USD 4.86B 286M 2024-12
Pacira USD 12.44M 43.69M 2025-03
Perrigo USD 146.6M 47.3M 2025-03
Pfizer USD 5.93B 1.31B 2025-03
Prestige Brands USD 100.89M 8.93M 2025-03
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.9B 824M 2025-03
Sanofi EUR 2.22B 2.84B 2024-12
Supernus Pharmaceuticals USD 48.3M 19.4M 2024-12
Zoetis USD 909M 79M 2025-03



Novartis - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.